"Unveiling the Ongoing Impact of Long COVID: Research Insights and Realities"
Four years into the long COVID pandemic, physicians have made progress in understanding and managing the condition, with 6.4% of Americans reporting symptoms. New treatments, including vagus nerve stimulation and beta-blockers, are showing promise in managing symptoms such as fatigue and rapid heartbeat. Clinical trials are exploring the potential of repurposed HIV antivirals and SARS-CoV-2 monoclonal antibodies as treatment options. However, there is a lack of urgency in research and funding for long COVID, despite its chronic nature and long-term impact on patients.